trending Market Intelligence /marketintelligence/en/news-insights/trending/aiYFmtmajuGKOduVtF9_1A2 content esgSubNav
In This List

Edwards Lifesciences closes Valtech Cardio acquisition

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Edwards Lifesciences closes Valtech Cardio acquisition

Edwards Lifesciences Corp. completed the acquisition of Israel-based Valtech Cardio Ltd. for $340 million in stock and cash.

In addition, the deal provides for the potential of up to $350 million in prespecified milestone-driven payments over the next 10 years.

Valtech is the developer of the cardioband system for transcatheter repair of the mitral and tricuspid valves.